$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The association between oral candidiasis and severity of chemoradiotherapy-induced dysphagia in head and neck cancer patients: A retrospective cohort study 원문보기

Clinical and translational radiation oncology, v.20, 2020년, pp.13 - 18  

Saito, Hirotake (Department of Radiation Oncology, Niigata University Medical and Dental Hospital) ,  Shodo, Ryusuke (Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences) ,  Yamazaki, Keisuke (Department of Otolaryngology Head and Neck Surgery, Niigata University Medical and Dental Hospital) ,  Katsura, Kouji (Department of Oral Radiology, Niigata University Medical and Dental Hospital) ,  Ueki, Yushi (Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences) ,  Nakano, Toshimichi (Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences) ,  Oshikane, Tomoya (Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences) ,  Yamana, Nobuko (Department of Radiation Oncology, Niigata University Medical and Dental Hospital Tanabe, Satoshi ,  Utsunomiya, Satoru ,  Ohta, Atsushi ,  Abe, Eisuke ,  Kaidu, Motoki ,  Sasamoto, Ryuta ,  Aoyama, Hidefumi

Abstract AI-Helper 아이콘AI-Helper

Abstract Background and purpose Concurrent chemoradiotherapy (CCRT) for head and neck cancer (HNC) is a risk factor for oral candidiasis (OC). As Candida spp. are highly virulent, we conducted a retrospective study to determine whether OC increases the severity of dysphagia related to mucositis in ...

주제어

참고문헌 (41)

  1. Lancet Oncol Lacas 18 9 1221 2017 10.1016/S1470-2045(17)30458-8 Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis 

  2. Radiother Oncol Pignon 92 1 4 2009 10.1016/j.radonc.2009.04.014 Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients 

  3. Ann Oncol Nguyen 15 3 383 2004 10.1093/annonc/mdh101 Dysphagia following chemoradiation for locally advanced head and neck cancer 

  4. J Clin Oncol Rosenthal 24 17 2636 2006 10.1200/JCO.2006.06.0079 Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer 

  5. Lancet Gillison 393 10166 40 2018 10.1016/S0140-6736(18)32779-X Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial 

  6. J Clin Oncol Noronha 36 11 1064 2018 10.1200/JCO.2017.74.9457 Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial 

  7. Lancet Oncol Chen 18 6 803 2017 10.1016/S1470-2045(17)30246-2 Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study 

  8. J Clin Oncol Feng 28 16 2732 2010 10.1200/JCO.2009.24.6199 Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results 

  9. Lancet Oncol Mesia 18 6 704 2017 10.1016/S1470-2045(17)30250-4 HPV-related oropharyngeal carcinoma de-escalation protocols 

  10. Int J Radiat Oncol Biol Phys Greco 101 2 421 2018 10.1016/j.ijrobp.2018.01.097 Dysphagia Treatment for Patients With Head and Neck Cancer Undergoing Radiation Therapy: A Meta-analysis Review 

  11. Int J Radiat Oncol Biol Phys Dahiya 57 1 79 2003 10.1016/S0360-3016(03)00415-2 Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer 

  12. J Clin Microbiol Redding 37 12 3896 1999 10.1128/JCM.37.12.3896-3900.1999 Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer 

  13. Nat Rev Immunol Netea 15 10 630 2015 10.1038/nri3897 Immune defence against Candida fungal infections 

  14. Sci Transl Med Brown 4 165 165rv13 2012 10.1126/scitranslmed.3004404 Hidden killers: human fungal infections 

  15. Radiother Oncol Busetto 109 2 303 2013 10.1016/j.radonc.2013.05.040 Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): a prospective longitudinal study 

  16. Int J Radiat Oncol Biol Phys Gligorov 80 2 532 2011 10.1016/j.ijrobp.2010.02.006 Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study 

  17. Pract Radiat Oncol Rao 3 3 229 2013 10.1016/j.prro.2012.05.008 Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer 

  18. Int J Radiat Oncol Biol Phys Sanguineti 83 1 235 2012 10.1016/j.ijrobp.2011.06.2000 Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer 

  19. Age Ageing Lacey 46 6 895 2017 10.1093/ageing/afx057 Evidence for strategies that improve recruitment and retention of adults aged 65 years and over in randomised trials and observational studies: a systematic review 

  20. Radiother Oncol Zenda 101 3 410 2011 10.1016/j.radonc.2011.09.016 Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy 

  21. Aust Dent J Farah 55 Suppl 1 48 2010 10.1111/j.1834-7819.2010.01198.x Oral fungal infections: an update for the general practitioner 

  22. Clin Infect Dis Pappas 62 4 e1 2016 10.1093/cid/civ1194 Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America 

  23. Int J Radiat Oncol Biol Phys Cox 31 5 1341 1995 10.1016/0360-3016(95)00060-C Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) 

  24. J Clin Oncol Le 29 20 2808 2011 10.1200/JCO.2010.32.4095 Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study 

  25. Int J Radiat Oncol Biol Phys Elting 68 4 1110 2007 10.1016/j.ijrobp.2007.01.053 Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies 

  26. Clin Infect Dis Vazquez 42 8 1179 2006 10.1086/501457 A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS 

  27. Int J Radiat Oncol Biol Phys Wang 64 3 692 2006 10.1016/j.ijrobp.2005.08.002 Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery 

  28. Bone Marrow Transplant Kanda 48 3 452 2013 10.1038/bmt.2012.244 Investigation of the freely available easy-to-use software 'EZR' for medical statistics 

  29. Nature Moyes 532 7597 64 2016 10.1038/nature17625 Candidalysin is a fungal peptide toxin critical for mucosal infection 

  30. Oral Dis Soysa 14 2 138 2008 10.1111/j.1601-0825.2006.01357.x Antimicrobials as a contributory factor in oral candidosis-a brief overview 

  31. Aids Dodd 5 11 1339 1991 10.1097/00002030-199111000-00009 Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS 

  32. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Redding 91 6 659 2001 10.1067/moe.2001.112946 Candida dubliniensis in radiation-induced oropharyngeal candidiasis 

  33. Am J Med Graybill 104 1 33 1998 10.1016/S0002-9343(97)00307-0 Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients 

  34. Clin Infect Dis Hamza 47 10 1270 2008 10.1086/592578 Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial 

  35. Clin Infect Dis Pons 24 6 1204 1997 10.1086/513664 Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions 

  36. Cancer Bensadoun 112 1 204 2008 10.1002/cncr.23152 

  37. Eur J Cancer Oude Lashof 40 9 1314 2004 10.1016/j.ejca.2004.03.003 An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis 

  38. Microbiol Mol Biol Rev Naglik 67 3 400 2003 10.1128/MMBR.67.3.400-428.2003 Candida albicans secreted aspartyl proteinases in virulence and pathogenesis 

  39. J Oral Pathol Med Reichart 24 6 276 1995 10.1111/j.1600-0714.1995.tb01182.x Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings 

  40. Radiother Oncol Popovtzer 93 3 510 2009 10.1016/j.radonc.2009.05.013 Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study 

  41. Support Care Cancer Nicolatou-Galitis 14 1 44 2006 10.1007/s00520-005-0835-2 Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로